Digital health care has been a key initiative at Texas Oncology, because it ensure patients can receive better care at their home, explained Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.
Digital health care has been a key initiative at Texas Oncology, because it ensures patients can receive better care at their home, explained Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.
Transcript
Rates of digital health solutions use are high at Texas Oncology based on findings presented at ASCO 2022. What do you attribute this high utilization to?
Well, it's been a key strategic initiative at Texas Oncology, if you think about how we use digital health care to improve the patient journey of cancer care. We've tried to use digital health care to make sure that patients can receive better care at their home. As you know, it's really Texas Oncology's mission to provide innovative and high-quality, affordable cancer care close to home.
So, really, digital health care is right in alignment with Texas Oncology's mission. And we've invested in a partnership with Navigating Cancer, to think about how we work with electronic patient-reported outcomes, to characterize patient's symptoms when they're on active treatment, to systematize patient care pathways when patients call into our triage nurses. And by doing this, by providing digital health solutions, we're able to decrease our response time to patients, we're able to characterize patients' symptoms better.
We think this is better care for patients. And while it's not easy, I think for any practice to adopt new digital health care tools, I think that this is the way of the future. This is how health care continues to innovate and support patients in ways that are easy to use for patients in their homes.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More